• TRM (USD/COP)COP 3,461.92 +1.37% +COP 46.82Colombia's official exchange rate (Financial Superintendence), valid Nov 21 to Nov 23
  • EuroCOP 3,804.64 +1.37% +COP 51.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote
  • Mexican pesoCOP 181.56 +1.37% +COP 2.45Reference: TRM crossed with the European Central Bank rate of Nov 20; not the market quote

SELLAS Life Sciences prices $150 million stock offering at $13 per share

FinanceInternationalTradingViewAI summary
Image: TradingView

SELLAS Life Sciences signed a placement agreement with J.P. Morgan Securities and TD Securities for a public offering of 11,538,462 common shares at $13 per share. The placement agents also received a 30-day option to buy up to 1,730,769 additional shares; if fully exercised, the company expects net proceeds of about $161.8 million after deducting discounts, commissions and estimated expenses. The offering is expected to close on or around November 20, 2026.

In 30 seconds

  • Public offering of 11,538,462 common shares at $13 each
  • J.P. Morgan Securities and TD Securities act as placement agents
  • 30-day option for up to 1,730,769 additional shares
Read the full story at TradingView

IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.

Comments

Be respectful. Comments reported by several people are hidden until a moderator reviews them.

You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.

    Keep reading